Organization
Department of Gastrointestinal and Medical Oncology, NHO Kyushu Cancer Center, Fukuoka, Japan
3 abstracts
Abstract
Efficacy and safety of combination therapy with binimetinib, encorafenib, and cetuximab for BRAF non-V600E mutated metastatic colorectal cancer: Results from a phase 2 BIG BANG trial (EPOC1703).Org: Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan, Translational Research Support Office, Division of Drug and Diagnostic Development Promotion, Department for the Promotion of Drug and Diagnostic Development, National Cancer Center Hospital East, Kashiwa, Japan, Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan, Aichi Cancer Center Hospital, Nagoya, Japan, Department of Gastrointestinal and Medical Oncology, NHO Kyushu Cancer Center, Fukuoka, Japan,
Abstract
Infrastructure for rare cancer in the Netherlands: Towards a comprehensive platform for early detection and diagnosis of rare cancers (FORCE).Org: The Netherlands Cancer Institute, Amsterdam/UMC Utrecht ENETS Centre of Excellence, Department of Endocrine Oncology, University Medical Center Groningen, Máxima Medical Center,
Abstract
Leg and walking self-exercise (LAWS) program for older adults with cancer during treatment.Org: Geriatric Oncology Service/Medical Oncology, NHO (National Hospital Organization) Kyushu Cancer Center, Fukuoka, Japan, Department of Biostatistics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan, Department of Nursing, NHO Kyushu Cancer Center, Fukuoka, Japan, Department of Gastrointestinal and Medical Oncology, NHO Kyushu Cancer Center, Fukuoka, Japan, Department of Gastroenterological Surgery, NHO Kyushu Cancer Center, Fukuoka, Japan,